1 Haucen BR,Alexander EK,Bible KC,et al.2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer:the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer[J].Thyroid,2016,26(1):1-133. 2 Teixeira G,Teixeira T,Gubert F,et al.The incidence of central neck micrometastatic disease in patients with papillary thyroid cancer staged pre-operatively and intraoperatively as N0[J].Surgery,2011,150(6):1161-1167. 3 Kim SY,Kim BW,Pyo JY,et al.Macrometastasis in papillary thyroid cancer patients is associated with higher recurrence in lateral neck nodes[J].World J Surg,2018,42(1):123-129. 4 Fu JY,Wu Y,Wang ZY,et al.Clinical and pathological analysis of central compartment dissection in patients with papillary thyroid cancer with negative clinical lymph node metastasis[J].Zhonghua Wai Ke Za Zhi,2007,45(7):470-472. 5 Amin SN,Shinn JR,Naguib MM,et al.Risk factors and outcomes of postoperative recurrent well-differentiated thyroid cancer:a single institution′s 15-year experience[J].Otolaryngol Head Neck Surg,2020,162(4):469-475. 6 Mehanna H,AI-Maqbili T,Carter B,et al.Differences in the recurrence and mortality outcomes rates of incidental and nonincidental papillary thyroid microcarcinoma:A systematic review and meta-analysis of 21329 person-years of follow-up[J].J Clin Endocrinol Metab,2014,99(8):2834-2843. 7 Liu LS,Liang J,Li JH,et al.The incidence and risk factors for central lymph node metastasis in cN0 papillary thyroid microcarcinoma:a meta-analysis[J].Eur Arch Otorhinolaryngol,2017,274(3):1327-1338. 8 Zhao W,You L,Hou X,et al.The effect of prophylactic central neck dissection on locoregional recurrence in papillary thyroid cancer after total thyroidectomy:a systematic review and meta-analysis :pCND for the locoregional recurrence of papillary thyroid cancer[J].Ann Surg Oncol,2017,24(8):2189-2198. 9 Liu H,Li Y,Mao Y,et al.Local lymph node recurrence after central neck dissection in papillary thyroid cancers:A meta analysis[J].Eur Ann Otorhinolaryngol Head Neck Dis,2019,136(6):481-487. 10Kim BY,Choi N,Kim SW,et al.Randomized trial of prophylactic ipsilateral central lymph node dissection in patients with clinically node negative papillary thyroid microcarcinoma[J].Eur Arch Otorhinolaryngol,2020,277(2):569-576. 11 Gui CY,Qiu SL,Peng ZH,et al.Clinical and pathologic predictors of central lymph node metastasis in papillary thyroid microcarcinoma:a retrospective cohort study [J].J Endocrinol Invest,2018,41(4):403-409. 12 Gu JH,Zhao YN,Xie RL,et al.Analysis of risk factors for cervical lymph node metastasis of papillary thyroid microcarcinoma:a study of 268 patients [J].BMC Endocr Disord,2019,19(1):124-124. 13 Adam MA,Pura J,Goffredo P,et al.Presence and number of lymph node metastases are associated with compromised survival for patients younger than age 45 years with papillary thyroid cancer[J].J Clin Onco,2015,33(21):2370-2375. 14 Feng JW,Pan H,Wang L,et al.Total tumor diameter:the neglected value in papillary thyroid microcarcinoma[J].J Endocrinol Invest,2020,43(5):601-613. 15 Virk RK,Van Dyke AL,Finkelstein A,et al.BRAFV600E mutation in papillary thyroid microcarcinoma:a genotype-phenotype correlation[J].Modern Pathol,2012,26(1):62-70. 16 Yip L,Nikiforova MN,Yoo JY,et al.Tumor genotype determines phenotype and disease-related outcomes in thyroid cancer:a study of 1510 patients[J].Ann Surg,2015,262(3):519-525. 17 Alzahrani AS,Xing M.Impact of lymph node metastases identified on central neck dissection(CND)on the recurrence of papillary thyroid cancer:potential role of BRAFV600E mutation in defining CND[J].Endocr Relat Cancer,2013,20(1),13-22. 18 Zheng X,Peng C,Gao M,et al.Risk factors for cervical lymph node metastasis in papillary thyroid microcarcinoma:a study of 1,587 patients[J].Cancer Biol Med,2019,16(1):121-130. 19 Zhang L,Wei WJ,Ji QH,et al.Risk factors for neck nodal metastasis in papillary thyroid microcarcinoma:a study of 1066 patients[J].J Clin Endocrinol Metab,2012,97(4):1250-1257. 20 Zhao HQ,Li H.Meta-analysis of ultrasound for cervical lymph nodes in papillary thyroid cancer:Diagnosis of central and lateral compartment nodal metastases.[J].Eur J Radiol,2019,112:14-21. 21 Wu X,Li B,Zheng C,et al.Risk factors for central lymph node metastases in patients with papillary thyroid microcarcinoma.[J].Endocr Pract,2018,24(12):1057-1062. 22 Abboud B,Smayra T,Jabbour H,et al.Correlations of neck ultrasound and pathology in cervical lymph node of papillary thyroid carcinoma[J].Acta Chir Belg,2019,25:1-7. 23 Horvath E,Majlis S,Rossi R,et al.An ultrasonogram reporting system for thyroid nodules stratifying cancer risk for clinical management[J].J Clin Endocr Metab,2009,94(5):1748-1751. 24 Wémeau JL,Sadoul JL,d′Herbomez M,et al.Guidelines of the French Society of Endocrinology for the management of thyroid nodules [J].Ann Endocrinol(Paris),2011,72(4):251-281. 25 Shin JH,Baek JH,Chung J,et al.Ultrasonography diagnosis and imaging-based management of thyroid nodules:Revised Korean Society of Thyroid Radiology consensus statement and recommendations [J].Korean J Radiol,2016,17(3):370-395. 26 付鹏,陈文,崔立刚,等.2017美国放射学会甲状腺影像学报告与数据系统应用价值探索[J].北京大学学报(医学版),2019,51(6):1067-1070. 27 Frasoldati A,Toschi E,Zini M,et al.Role of thyroglobulin measurement in fine-needle aspiration biopsies of cervical lymph nodes in patients with differentiated thyroid cancer[J].Thyroid,1999,9(2):105-111. 28 Frasoldati A,Valcavi R.Challenges in neck ultrasonography:Lymph-adenopathy and parathyroid glands[J].Endocrine Prac,2004,10(3):261-268. 29 Tseng FY,Hsiao YL,Chang TC.Cytologic features of metastatic papillary thyroid carcinoma in cervical lymph nodes[J].Acta Cytol,2002,46(6):1043-1048. 30 Pacini F,Fugazzola L,Lippi F,et al.Detection of thyroglobulin in fine needle aspirates of nonthyroidal neck masses:A clue to the diagnosis of metastatic differentiated thyroid cancer[J].J Clin Endocrinol Metab,1992,74(6):1401-1404. 31 Lee MJ,Ross DS,Mueller PR,et al.Fine-needle biopsy of cervical lymph nodes in patients with thyroid cancer:A prospective comparison of cytopathologic and tissue marker analysis[J].Radiology,1993,187(3):851-854. 32 Jeong HS,Baek CH,Son YI,et al.Integrated 18F-FDG PET/CT for the initial evaluation of cervical node level of patients with papillary thyroid carcinoma:comparison with ultrasound and contrast-enhanced CT[J].Clin Endocrinol(Oxf),2006,65(3):402-407. 33 Suh CH,Baek JH,Choi YJ,et al.Performance of CT in the preoperative diagnosis of cervical lymph node metastasis in patients with papillary thyroid cancer:a systematic review and meta-analysis[J].Am J Neuroradiol,2017,38(1):154-161. 34 Kim BS,Kim SJ,Kim IJ,et al.Factors associated with positive F-18 flurodeoxyglucose positron emission tomography before thyroidectomy in patients with papillary thyroid carcinoma[J].Thyroid,2012,22(7):725-729. 35 Morita S,Mizoguchi K,Suzuki M,et al.The accuracy of(18)[F]-fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography,ultrasonography,and enhanced computed tomography alone in the preoperative diagnosis of cervical lymph node metastasis in patients with papillary thyroid carcinoma[J].World J Surg,2010,34(11):2564-2569. 36 Chen Q,Raghavan P,Mukherjee S,et al.Accuracy of MRI for the diagnosis of metastatic cervical lymphadenopathy in patients with thyroid cancer[J].Radiol Med,2015,120(10):959-966. 37 Sancho JJ,Lennard TW,Paunovic I,et al.Prophylactic central neck disection in papillary thyroid cancer:a consensus report of the European Society of Endocrine Surgeons(ESES)[J].Langenbecks Arch Surg,2014,399(2):155-163. 38 高明.甲状腺结节和分化型甲状腺癌诊治指南[J].中国肿瘤临床,2012,39(17):1249-1272. 39 中国抗癌协会甲状腺癌专业委员会.甲状腺微小乳头状癌诊断与治疗中国专家共识(2016版)[J].中国肿瘤临床,2016,43(12):526-526. 40 Yoo HS,Shin MC,Ji YB,et al.Optimal extent of prophylactic central neck dissection for papillary thyroid carcinoma:Comparison of unilateral versus bilateral central neck dissection[J].Asian J Surg,2018,41(4):363-369. 41 Yoo BJ,Song CM,Ji YB,et al.Efficacy of central neck dissection for clinically node-negative papillary thyroid carcinoma:propensity scoring matching[J].Front Endocrinol,2019,10:172-172. 42 Raffaelli M,De Crea C,Sessa L,et al.Prospective evaluation of total thyroidectomy versus ipsilateral versus bilateral central neck dissection in patients with clinically node-negative papillary thyroid carcinoma[J].Surgery,2012,152(6):957-964. 43 Dobrinja C,Troian M,Cipolat Mis T,et al.Rationality in prophylactic central neck dissection in clinically node-negative(cN0)papillary thyroid carcinoma:Is there anything more to say? A decade experience in a single-center[J].Int J Surg,2017,41(Suppl 1):40-47. 44 Son YI,Jeong HS,Baek CH,et al.Extent of prophylactic lymph node dissection in the central neck area of the patients with papillary thyroid carcinoma:comparison of limited versus comprehensive lymph node dissection in a 2-year safety study[J].Ann Surg Oncol,2008,15(7):2020-2026. 45 孔繁巍,赵长久.分化型甲状腺癌碘131治疗后的外周血细胞改变[J].实用肿瘤学杂志,2018,32(5):476-479. 46 Hay ID,Hutchinson ME,Gonzalez-Losada T,et al.Papillary thyroid microcarcinoma:a study of 900 cases observed in a 60-year period[J].Surgery,2008,144(6):980-987. 47 Wang TS,Goffredo P,Sosa JA,et al.Papillary thyroid microcarcinoma:an over-treated malignancy[J].World J Surg,2014,38(9):2297-2303. 48 Momesso DP,Vaisman F,Yang SP,et al.Dynamic risk stratification in patients with differentiated thyroid cancer treated without radioactive Iodine[J].J Clin Endocr Metab,2016,101(7):2692-2700. |